the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Pharmaceutical Mergers and Acquisitions

Published by Cutting Edge Information Contact us : +1-860-674-8796
Published 2009/10 Content info  
Product code CEI102381
Price From  US $ 7695 Order/Price list
US $ 7695 PDF by E-mail (Single User License)
US $ 15995 PDF by E-mail (Multi User License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

Chapter 1: Deal Background

  • General reasons for pursuing all deals (buyers and sellers)
  • Reasons for pursuing deals (buyers)
  • Reasons for pursuing deals (sellers)
  • Increase/decrease in M&A activity in the past 12 months (among buyers and sellers)
  • What was the total price of the deal?
  • How long did the deal take?
  • How were you involved in the deal?
  • Which company initiated acquisition discussions?

Chapter 2: Deal Foundations and Integration Processes

  • Group first processing M&A opportunities - broken down for both the purchasing and acquired companies
  • Percentage of mergers using formal integration processes
  • Percentage of mergers using integration teams
  • Composition of integration team
  • Percentage of companies which had completed their integration processes by month

Chapter 3: Resolving Integration Challenges

Metrics address post-merger challenges in the following areas:

  • Corporate culture
  • Human resources
  • Attrition
  • Rate of post-merger attrition, by company

Chapter 4: Pharmaceutical Mergers and Acquisitions - 2008 to 2009

  • Ratio of purchase price to annual revenue, by deal type
  • Percentage of companies with a drug through at least each phase, $100 million to $1 billion
  • Time between agreement signing and deal closing, in days
  • Type of financing used, by deal type
  • Type of financing used by large (mid-size, small) companies

Chapter 5: The Future of M&A

  • Size and type of company acting as purchaser
  • Size and type of company acting as seller
  • Number of deals pursued for each merger type
  • Average purchase price by merger type
  • Percentage of companies with a drug through at least each phase, $100 million to $1 billion values within dollar ranges

Chapter 6: Deal Profiles

Profiles of 19 deals; 11 profiles are from the buyer' s perspective and eight are from the seller' s perspective. Profiles include the following elements:

Background Information

  • Deal background
  • M&A task force activities
  • Purpose for pursuing deal

Integration Process

  • Integration timeline
  • Structure of integration team
  • External advisors

Employee Retention and Merger Challenges

  • Employees retained from acquiring company
  • Problems encountered during merger process
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.